2603 Stock Overview
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||CN¥22.84|
|52 Week High||CN¥43.12|
|52 Week Low||CN¥15.38|
|1 Month Change||-9.04%|
|3 Month Change||-13.84%|
|1 Year Change||18.16%|
|3 Year Change||212.57%|
|5 Year Change||91.36%|
|Change since IPO||86.07%|
Recent News & Updates
|2603||CN Pharmaceuticals||CN Market|
Return vs Industry: 002603 exceeded the CN Pharmaceuticals industry which returned -15.8% over the past year.
Return vs Market: 002603 exceeded the CN Market which returned -10.4% over the past year.
|2603 Average Weekly Movement||6.6%|
|Pharmaceuticals Industry Average Movement||5.6%|
|Market Average Movement||6.1%|
|10% most volatile stocks in CN Market||9.2%|
|10% least volatile stocks in CN Market||3.9%|
Stable Share Price: 002603 is not significantly more volatile than the rest of CN stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: 002603's weekly volatility (7%) has been stable over the past year.
About the Company
|1992||15,155||Xiang Jun Wu||https://www.yiling.cn|
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of medicine primarily in China. The company operates through Chemical and Biological Medicine, and Health Industry segments. It offers drugs for cardiac and premature ventricular beats, sinus bradycardia, chronic heart failure, integrated rhythm regulation, cold and respiratory, cardiovascular and cerebrovascular diseases, diabetes field, tumor medication, and others.
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Fundamentals Summary
|2603 fundamental statistics|
Is 2603 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|2603 income statement (TTM)|
|Cost of Revenue||CN¥3.45b|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||0.69|
|Net Profit Margin||12.58%|
How did 2603 perform over the long term?See historical performance and comparison